Optimal Timing of Surgical Excision in Pediatric Pilomatricoma: Association between Clinicopathological Features and Cosmetic Outcomes
- PMID: 33911719
- PMCID: PMC7992542
- DOI: 10.5021/ad.2020.32.2.93
Optimal Timing of Surgical Excision in Pediatric Pilomatricoma: Association between Clinicopathological Features and Cosmetic Outcomes
Abstract
Background: The treatment of choice for pilomatricomas is surgical excision; however, data for the optimal timing of treatment and cosmetic outcomes are limited.
Objective: This study aimed to investigate the optimal timing of treatment in pilomatricomas by considering clinicopathological findings and cosmetic outcomes.
Methods: Seventy-three pilomatricomas patients aged ≤15 years were retrospectively reviewed. Patients were classified into early excision (disease duration ≤12 months, group A) and delayed excision groups (disease duration >12 months, group B). Tumor characteristics, and histopathological features with evolutionary stages were assessed. Cosmetic outcomes were evaluated by the Modified Vancouver Scar Scale (MVSS), 5-point patient satisfaction score, and complication rates.
Results: Group A showed better cosmetic outcomes than group B in the MVSS (1.53±1.22 vs. 3.68±1.84), 5-point patient satisfaction score (4.08±0.89 vs. 3.18±1.01), and complication rates (11.8% vs. 36.4%), respectively (p<0.05). Secondary anetoderma, tent sign, calcification, and late regressive stage (evolutionary stage IV) were more common in group B, (p<0.05). Moreover, evolutionary stages showed a positive correlation with mean MVSS (r=0.670, p<0.05).
Conclusion: Early excision (disease duration ≤12 months) provides superior cosmetic outcomes compared to delayed procedures. Early recognition, diagnosis, and management for pediatric pilomatricomas is important to improve overall cosmetic outcomes.
Keywords: Cosmetic outcomes; Evolutionary stages; Pilomatricoma; Surgical excision; Surgical outcomes.
Copyright © 2020 The Korean Dermatological Association and The Korean Society for Investigative Dermatology.
Conflict of interest statement
CONFLICTS OF INTEREST: The authors have nothing to disclose.
Figures





References
-
- Julian CG, Bowers PW. A clinical review of 209 pilomatricomas. J Am Acad Dermatol. 1998;39(2 Pt 1):191–195. - PubMed
-
- Pirouzmanesh A, Reinisch JF, Gonzalez-Gomez I, Smith EM, Meara JG. Pilomatrixoma: a review of 346 cases. Plast Reconstr Surg. 2003;112:1784–1789. - PubMed
-
- Srivastava D, Taylor RS. Appendage tumors and hamartomas of the skin. In: Fitzpatrick TB, Goldsmith LA, editors. Fitzpatrick's dermatology in general medicine. Vol. 1. 8th ed. New York: McGraw-Hill Medical; 2012.
-
- Jones CD, Ho W, Robertson BF, Gunn E, Morley S. Pilomatrixoma: a comprehensive review of the literature. Am J Dermatopathol. 2018;40:631–641. - PubMed
-
- Kaddu S, Soyer HP, Hödl S, Kerl H. Morphological stages of pilomatricoma. Am J Dermatopathol. 1996;18:333–338. - PubMed
LinkOut - more resources
Full Text Sources